Hereditary spinocerebellar ataxia
ICD-10 G11.9 · ICD-11 8A03.1Z

Treatment of Hereditary Spinocerebellar Ataxia with Disabling Nystagmus or Oscillopsia

In patients with hereditary spinocerebellar ataxia, nystagmus can emerge as a neurological symptom and may give rise to oscillopsia — a disabling subjective sensation that the visual world is in motion. When either symptom becomes disabling, it requires active clinical management.

Clinical situation This protocol applies to patients with hereditary spinocerebellar ataxia in whom nystagmus is sufficiently severe to impair daily functioning, or in whom oscillopsia is present. The combination significantly affects quality of life and warrants targeted pharmacological intervention.
Treatment approach (partial) When disabling nystagmus or oscillopsia is present in this setting, pharmacological treatment is recommended. A specific agent is used — selection, sequencing, and full prescribing details are available in the complete protocol.

Full regimen, dosing, and clinical algorithm available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Nystagmus can be a symptom experienced by patients with ataxias and it can sometimes also cause oscillopsia (a disabling subjective sensation of movement of the visual world).

If disabling nystagmus or oscillopsia is present treatment is recommended, often with either gabapentin or baclofen.

View source ↗